Medicinal Cannabis Use Among People with Obsessive Compulsive Disorder: Changes in Quality of Life After Three Months
Obsessive–compulsive disorder (OCD) has an estimated prevalence between 1 and 2.3%. Existing treatments may not be suitable or effective for all people with OCD, and there is increasing interest in whether these individuals may benefit from the use of cannabis-based medical products (CBMPs). We docu...
Saved in:
Main Authors: | Michael T. Lynskey, Alkyoni Athanasiou-Fragkouli, Anne K. Schlag, David J. Nutt |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-06-01
|
Series: | Psychoactives |
Subjects: | |
Online Access: | https://www.mdpi.com/2813-1851/4/2/16 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical characteristics of obsessive-compulsive disorder comorbid with obsessive -compulsive personality disorder: subtype implications
by: Ayse Dondu, et al.
Published: (2025-07-01) -
The bidirectional relationship between severity of obsessive-compulsive symptoms and lifestyle factors in patients with obsessive-compulsive disorder: a contemporaneous and prospective analysis
by: Johanna A. M. du Mortier, et al.
Published: (2025-07-01) -
Obsessive-compulsive disorder /
by: Rachman, Stanley
Published: (2009) -
Single-dose (10 mg) psilocybin reduces symptoms in adults with obsessive-compulsive disorder: A pharmacological challenge study
by: Luca Pellegrini, et al.
Published: (2025-10-01) -
Mapping research trends in obsessive-compulsive disorder before and after the COVID-19 pandemic: a bibliometric analysis focusing on its molecular mechanisms
by: Yuito Inoue, et al.
Published: (2025-07-01)